You’ve done the blood work. The HSG showed open tubes. The semen analysis came back normal. Your AMH is fine, your thyroid is fine, your cycle is regular. And still—month after month—you’re not pregnant.
This is unexplained infertility, and it is the most frustrating diagnosis in reproductive medicine. Not because there’s nothing wrong, but because the standard fertility workup can’t identify what it is. Roughly 30% of couples who undergo a complete infertility evaluation receive this diagnosis. It means: we tested everything we know how to test, and we didn’t find the problem.
That doesn’t mean there is no problem. It means the problem is beyond the resolution of current diagnostic tools. And understanding that distinction—between “nothing is wrong” and “we can’t find what’s wrong”—is essential to making informed treatment decisions.
What “Unexplained” Actually Means
A diagnosis of unexplained infertility is given when a couple has been trying for 12 months (or 6 months if the woman is over 35) and a standard workup reveals no identifiable cause. The standard workup typically includes ovulation confirmation (via bloodwork, ultrasound, or OPK tracking), semen analysis (count, motility, morphology), tubal patency testing (HSG or sonohysterogram), ovarian reserve testing (AMH, FSH, antral follicle count), and thyroid and hormone panel screening.
If all of these come back within normal ranges, the diagnosis is unexplained infertility. But this workup, while comprehensive by current standards, has significant blind spots.
What the Standard Workup Misses
Egg quality. There is currently no test that directly measures egg quality. AMH and antral follicle count tell you about quantity (how many eggs remain), not quality (whether those eggs can produce a healthy embryo). Egg quality declines with age and is a major contributor to infertility, but it is invisible to standard diagnostics.
Sperm DNA fragmentation. A conventional semen analysis measures count, motility, and morphology—but not the integrity of the DNA inside each sperm. High sperm DNA fragmentation can prevent normal embryo development even when the semen analysis looks perfectly normal. A sperm DNA fragmentation test is available but is not routinely included in a standard fertility workup.
Subtle endometriosis. Mild (Stage I–II) endometriosis can impair fertility through inflammation and altered pelvic environment without being visible on imaging. It can only be definitively diagnosed via laparoscopy, which is an invasive surgical procedure and is not part of a standard workup.
Implantation factors. Even if an egg fertilizes normally and an embryo develops, implantation into the uterine lining can fail for reasons that are poorly understood and currently unmeasurable. The ERA test attempts to address one aspect of this (timing of endometrial receptivity), but its clinical benefit remains debated.
Immune factors. Some research suggests that immune system abnormalities may prevent successful implantation, but this area remains controversial and testing is not standardized.
Treatment Options: What the Evidence Supports
Timed Intercourse With Lifestyle Optimization
For couples under 35 who have been trying for less than two years, continued timed intercourse is sometimes recommended—especially if lifestyle factors (weight, nutrition, alcohol, smoking) haven’t been fully optimized. A good prenatal multivitamin for her and a CoQ10-based male fertility supplement for him can address nutritional gaps while you continue trying naturally. See LifeFertile’s coverage of evidence-based supplement protocols for more detail.
However, the per-cycle natural conception rate for couples with unexplained infertility is approximately 2–4%—significantly lower than the 15–25% monthly rate for fertile couples. Continued unassisted trying has diminishing returns, especially with advancing age.
Medicated IUI
Clomiphene citrate or letrozole combined with intrauterine insemination (IUI) is the most commonly recommended first-line treatment for unexplained infertility. It addresses two potential hidden factors simultaneously: mild ovulatory dysfunction (by ensuring multiple follicles develop) and sperm transport issues (by placing concentrated sperm directly in the uterus).
Success rates for medicated IUI in unexplained infertility are approximately 8–15% per cycle. Three to four cycles are typically attempted before escalation. For a detailed framework on when to move from IUI to IVF, see ConceiveGuide’s IUI vs. IVF escalation guide.
IVF
IVF is the most effective treatment for unexplained infertility, with per-cycle success rates of 40–55% for women under 35. It is both diagnostic (revealing egg quality, fertilization capacity, and embryo development) and therapeutic (bypassing whatever hidden barrier is preventing natural conception).
Some research suggests that proceeding directly to IVF—rather than first spending months on IUI—produces superior cumulative pregnancy rates in fewer treatment cycles and less total time. This is particularly relevant for women over 35, where time spent on lower-probability treatments has a real opportunity cost. For success rate data by age, see ConceiveGuide’s IVF success rates by age.
Advanced Testing Worth Discussing With Your RE
Beyond the standard workup, several additional tests can sometimes uncover a treatable factor in cases labeled “unexplained.” Not all of these are routinely offered, and not all are appropriate for every patient, but they’re worth knowing about.
Sperm DNA fragmentation (SDF) testing. A standard semen analysis measures count, motility, and morphology but tells you nothing about the integrity of the DNA packaged inside each sperm. High SDF (above 30% using the SCSA method) has been associated with lower pregnancy rates, higher miscarriage rates, and failed IVF cycles—even when the conventional semen analysis looks normal. Testing is straightforward and typically costs $200–$400. If SDF is elevated, lifestyle modifications (antioxidant supplementation, reducing heat exposure, addressing varicocele if present) can improve it in some cases.
Hysteroscopy. An HSG can show whether the fallopian tubes are open, but it provides limited information about the uterine cavity itself. A hysteroscopy—a procedure where a thin camera is inserted through the cervix to directly visualize the uterine lining—can detect small polyps, fibroids, adhesions, or a uterine septum that an HSG might miss. These findings are treatable and can meaningfully improve the chances of both natural conception and IVF success.
Antiphospholipid antibody testing. Antiphospholipid syndrome is an autoimmune condition that increases the risk of blood clots and can cause recurrent pregnancy loss and implantation failure. A simple blood test can screen for the antibodies, and treatment (typically low-dose aspirin and heparin) is well-established if the test is positive.
Endometrial biopsy. Some REs recommend an endometrial biopsy to assess the uterine lining for chronic endometritis (a low-grade infection that can interfere with implantation) or to evaluate receptivity through ERA testing. The evidence for ERA testing remains debated (see ConceiveGuide’s ERA testing analysis), but screening for chronic endometritis with a simple biopsy and treating with antibiotics if found can be clinically meaningful.
The Emotional Weight of “We Don’t Know Why”
Unexplained infertility carries a particular emotional burden. With a diagnosed cause—blocked tubes, low sperm count, PMOS—you have something to point to, something to treat, something to explain to friends and family. With unexplained infertility, you have a vacuum, and that vacuum fills with self-doubt, guilt, and the nagging feeling that you must be missing something.
You’re not. The diagnostic tools have limits, and “unexplained” reflects those limits, not your body’s inadequacy. If the emotional weight is heavy—and for many couples it is—a reproductive psychologist can provide strategies specific to the ambiguity of this diagnosis.
What to Do Next
If you’ve received an unexplained infertility diagnosis, ask your RE about additional testing beyond the standard workup: sperm DNA fragmentation analysis, a hysteroscopy to evaluate the uterine cavity directly, and thyroid antibody testing. These tests don’t always change the diagnosis, but they can sometimes reveal a treatable factor that the initial workup missed.
Then, make a treatment plan with clear decision points: how many IUI cycles you’ll try before escalating to IVF, what your financial ceiling is, and how you and your partner will support each other through the uncertainty. Having a plan doesn’t eliminate the frustration, but it channels it into action.
Considering Fertility Treatment?
If you’ve been trying and want to explore your options, we can help you find the right path forward.
Explore Your Options →FTC Disclosure: Some links in this article are affiliate links. If you purchase through them, we may earn a small commission at no extra cost to you. This does not influence our recommendations, which are based on evidence and editorial judgment.